Physician profile
John Patrick Marino
NPI 1922112523
$2,350.40
in general payments reported to CMS, 2019-2025
20 companies · $74.43 in 2025
The $74.43 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $359 · 2021: $184 · 2022: $470 · 2023: $59.72 · 2024: $21.98 · 2025: $74.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $697.35 | 2019-2024 | Nucala, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $530.36 | 2019-2023 | Farxiga |
| Amgen INC. | $208.46 | 2019-2020 | |
| Novo Nordisk INC | $144.78 | 2022-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $125.14 | 2019-2021 | |
| Allergan, INC. | $125.01 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $73.08 | 2019-2025 | Camzyos |
| Medtronic USA, INC. | $70.41 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $61.87 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $54.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $53.12 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.63 | 2019-2021 | |
| Heartflow, INC. | $35.91 | 2025 | |
| Sanofi-Aventis U.S. LLC | $28.70 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.28 | 2023 | Glassia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $19.34 | 2019 | |
| Amarin Pharma, INC. | $15.05 | 2020 | |
| Lilly USA, LLC | $13.84 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.81 | 2019 | |
| Pfizer INC. | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.